A role for the endogenous cannabinoid system in the peripheral control of pain initiation

Progress in Brain Research

Volumn 129, Issue , 2000, Pages 471-482

  Calignano, Antonio ^a   La Rana, Giovanna ^a   Loubet Lescoulié, Patrick ^b   Piomelli, Daniele ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANALGESIC AGENT; ANANDAMIDE; ARACHIDONIC ACID; CANNABINOID; CANNABINOID RECEPTOR; ETHANOLAMINE DERIVATIVE;

ANALGESIA; ANTINOCICEPTION; ARTICLE; CELLULAR DISTRIBUTION; NOCICEPTION; NOCICEPTIVE RECEPTOR; PAIN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

EID: 0034589602     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(00)29034-1     Document Type: Article

References (71)

1. Aloe, L., Leon, A. and Levi-Montalcini, R. (1993) A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions, 39: C145-147.
2. Bachur, N.R., Masek, K., Melmon, K.L. and Udenfriend, S. (1965) Fatty acid amides of ethanolamine in mammalian tissues. J. Biol. Chem., 240: 1019-1024.
3. Beltramo, M. and Piomelli, D. (2000) Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid, 2-arachidonylglycerol. Neuroreport, 11: 1231-1235.
4. Beltramo, M., Stella, N., Calignano, A., Lin, S.Y., Makriyannis, A. and Piomelli, D. (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science, 277: 1094-1097.
5. 2-receptor responses by an anandamide transport inhibitor. J. Neurosci., 20: 3401-3407.
6. Bouaboula, M., Dussossoy, D. and Casellas, P. (1999) Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses. J. Biol. Chem., 274: 20397-20405.
7. Cadas, H., Gaillet, S., Beltramo, M., Venance, L. and Piomelli, D. (1996) Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J. Neurosci., 16: 3934-3942.
8. Calignano, A., La Rana, G., Giuffrida, A. and Piomelli, D. (1998) Control of pain initiation by endogenous cannabinoids. Nature, 394: 277-281.
9. Cravatt, B.F., Giang, D.K., Mayfield, S.P., Boger, D.L., Lerner, R.A. and Gilula, N.B. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature, 384: 83-87.
10. Desarnaud, E, Cadas, H. and Piomelli, D. (1995) Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J. Biol. Chem., 270: 6030-6035.
11. Devane, W.A., Dysarz, F.A.d., Johnson, MR., Melvin, L.S. and Howlett, A.C. (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol., 34: 605-613.
12. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. and Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258:1946-1949.
13. Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.C. and Piomelli, D. (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature, 372: 686-691.
14. Di Matzo, V., Bisogno, T., Sugiura, T., Melck, D. and De Petrocellis, L. (1998) The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: Connections with anandamide. Biochem. J., 331: 15-19.
15. Dubuisson, D. and Dennis, S.G. (1977) The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain, 4: 161-174.
16. Facci, L., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S.D. and Leon, A. (1995) Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. USA, 92: 3376-3380.
17. Galiegue, S., Mary, S., Marchand, J., Dussossoy, D., Carriere, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G. and Casellas, P. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem., 232: 54-61.
18. Giang, D.K. and Cravatt, B.F. (1997) Molecular characterization of human and mouse fatty acid amide hydrolases. Proc. Natl. Acad. Sci. USA, 94: 2238-2242.
19. Giuffrida, A. and Piomelli, D. (1998) Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. FEBS Lett., 422: 373-376.
20. Giuffrida, A., Parsons, L.H., Kerr, T.M., Rodriguez de Fonseca, F., Navarro, M. and Piomelli, D. (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci., 2: 358-363.
21. Giuffrida, A., Rodríguez de Fonseca, F. and Piomelli, D. (2000) Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry. Anal. Biochem., 280: 87-93.
22. Goparaju, S.K., Ueda, N., Yamaguchi, H. and Yamamoto, S. (1998) Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett., 422: 69-73.
23. Goparaju, S.K., Ueda, N., Taniguchi, K. and Yamamoto, S. (1999) Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem. Pharmacol., 57: 417-423.
24. Hanus, L., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R.G., Ross, R.A., Mechoulam, R. and Fride, E. (1999) HU-308: A specific agonist for CB(2), a peripheral cannabinoid receptor. Proc. Natl. Acad. Sci. USA, 96:14228-14233.
25. Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S., De Costa, B.R. and Rice, K.C. (1990) Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA, 87:1932-1936.
26. Herkenham, M., Groen, B.G., Lynn, A.B., De Costa, B.R. and Richfield, E.K. (1991a) Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum. Brain Res., 552: 301-310.
27. Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., De Costa, B.R. and Rice, K.C. (1991b) Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J. Neurosci., 11: 563-583.
28. Hillard, C.J., Wilkison, D.M., Edgemond, W.S. and Campbell, W.B. (1995) Characterization of the kinetics and distribution of N- arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochim. Biophys. Acta, 1257: 249-256.
29. Hillard, C.J., Edgemond, W.S., Jarrahian, A. and Campbell, W.B. (1997) Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J. Neurochem., 69: 631-638.
30. Hohmann, A.G. and Herkenham, M. (1999a) Cannabinoid receptors undergo axonal flow in sensory nerves. Neuroscience, 92: 1171-1175.
31. Hohmann, A.G. and Herkenham, M. (1999b) Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: A double-label in situ hybridization study. Neuroscience, 90: 923-931.
32. Hohmann, A.G., Briley, E.M. and Herkenham, M. (1999a) Pre-and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord. Brain Res., 822: 17-25.
33. Hohmann, A.G., Tsou, K. and Walker, J.M. (1999b) Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat. J. Neurophysiol., 81: 575-583.
34. Howlett, A.C. (1995) Pharmacology of cannabinoid receptors. Annu. Rev. Phannacol. Toxicol., 35: 607-634.
35. Ingram, S.L. (2000) Cellular and molecular mechanisms of opioid action. In J. Sandkühler, B. Bromm and G.F. Gebhart (Eds.), Nervous System Plasticity and Chronic Pain. Progress in Brain Research, Vol. 129. Elsevier, Amsterdam, pp. 483-492.
36. Inoue, M., Kobayashi, M., Kozaki, S., Zimmer, A. and Ueda, H. (1998) Nociceptin/orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve endings in mice. Proc. Natl. Acad. Sci. USA, 95: 10949-10953.
37. Jaggar, S.I., Hasnie, F.S., Sellaturay, S. and Rice, A.S. (1998a) The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain, 76: 189-199.
38. Jaggar, S.I., Sellaturay, S. and Rice, A.S. (1998b) The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder. Neurosci. Lett., 253: 123-126.
39. Jin, W., Brown, S., Roche, J.P., Hsieh, C., Celver, J.P., Kovoor, A., Chavkin, C. and Mackie, K. (1999) Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. J. Neurosci., 19: 3773-3780.
40. Ko, M.C. and Woods, J.H. (1999) Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: A peripheral cannabinoid action. Psychopharmacology (Berl.), 143: 322-326.
41. Kolesnikov, Y.A. and Pasternak, G.W. (1999) Peripheral blockade of topical morphine tolerance by ketamine. Eur. J. Pharmacol., 374: R1-2.
42. Lichtman, A.H. and Martin, B.R. (1996) Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology (Berl.), 126: 125-131.
43. Machelska, H., Pfluger, M., Weber, W., Piranvisseh-Volk, M., Daubert, J.D., Dehaven, R. and Stein, C. (1999) Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans. J. Pharmacol. Exp. Ther., 290: 354-361.
44. Martin, W.J., Hohmann, A.G. and Walker, J.M. (1996) Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: Correlation between electrophysiological and antinociceptive effects. J. Neurosci., 16: 6601-6611.
45. Matsuda, L.A. (1997) Molecular aspects of cannabinoid receptors. Crit. Rev. Neurobiol., 11: 143-166.
46. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C. and Bonner, T.I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346: 561-564.
47. Matsuda, L.A., Bonner, T.I. and Lolait, S.J. (1993) Localization of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol., 327: 535-550.
48. Mazzari, S., Canella, R., Petrelli, L., Marcolongo, G. and Leon, A. (1996) N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur. J. Pharmacol., 300:227-236.
49. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R., Gopher, A., Almog, S., Martin, B.R. and Compton, D.R. et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol., 50: 83-90.
50. Meng, I.D., Manning, B.H., Martin, W.J. and Fields, H.L. (1998) An analgesia circuit activated by cannabinoids. Nature, 395: 381-383.
51. Munro, S., Thomas, K.L. and Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365: 61-65.
52. Pertwee, R.G. (1999) Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors. Life Sci., 65: 597-605.
53. Piomelli, D., Beltramo, M., Giuffrida, A. and Stella, N. (1998) Endogenous cannabinoid signaling. Neurobiol. Dis., 5: 462-473.
54. Piomelli, D., Beltramo, M., Glasnapp, S., Lin, S.Y., Goutopoulos, A., Xie, X.Q. and Makriyannis, A. (1999) Structural determinants for recognition and translocation by the anandamide transporter. Proc. Natl. Acad. Sci. USA, 96: 5802-5807.
55. Richardson, J.D., Kilo, S. and Hargreaves, K.M. (1998) Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain, 75: 111-119.
56. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrara, P., Soubrié, P., Brelière, J.C. and Le Fur, G. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett., 350: 240-244.
57. Rinaldi-Carmona, M., Barth, F., Millan, J., Derocq, J.M., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., Portier, M., Shire, D., Breliere, J.C. and Le Fur, G.L. (1998) SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther, 284: 644-650.
58. Schmid, P.C., Zuzarte-Augustin, M.L. and Schmid, H.H. (1985) Properties of rat liver N-acylethanolamine amidohydrolase. J. Biol. Chem., 260: 14145-14149.
59. Showalter, V.M., Compton, D.R., Martin, B.R. and Abood, M.E. (1996) Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther., 278: 989-999.
60. Sim, L.J., Hampson, R.E., Deadwyler, S.A. and Childers, S.R. (1996) Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain. J. Neurosci., 16: 8057-8066.
61. Stein, C. (1991) Peripheral analgesic actions of opioids. J. Pain Symptom Manage., 6: 119-124.
62. Stein, C., Hassan, A.H., Przewlocki, R., Gramsch, C., Peter, K. and Herz, A. (1990) Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc. Natl. Acad. Sci. USA, 87: 5935-5939.
63. Stella, N., Schweitzer, P. and Piomelli, D. (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature, 388: 773-778.
64. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A. and Waku, K. (1995) 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun., 215: 89-97.
65. (2+)-dependent transacylase and phosphodiesterase activities. Biochem. Biophys. Res. Commun., 218: 113-117.
66. Tsou, K., Lowitz, K.A., Hohmann, A.G., Martin, W.J., Hathaway, C.B., Bereiter, D.A. and Walker, J.M. (1996) Suppression of noxious stimulus-evoked expression of FOS protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist. Neuroscience, 70: 791-798.
67. Tsou, K., Brown, S., Sanudo-Pena, M.C., Mackie, K. and Walker, J.M. (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience, 83:393-411.
68. Ueda, N., Kurahashi, Y., Yamamoto, S. and Tokunaga, T. (1995) Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J. Biol. Chem., 270: 23823-23827.
69. Walker, J.M., Huang, S.M., Strangman, N.M., Tsou, K. and Sanudo-Pena, M.C. (1999) Pain modulation by release of the endogenous cannabinoid anandamide. Proc. Natl. Acad. Sci. USA, 96: 12198-12203.
70. Yaksh, T.L. and Reddy, S.V. (1981) Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen. Anesthesiology, 54: 451-467.
71. Zimmer, A., Zimmer, A.M., Hohmann, A.G., Herkenham, M. and Bonner, T.I. (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. USA, 96: 5780-5785.